Leadless pacing in cardiac transplant recipients: Primary results of a multicenter case experience

J Electrocardiol. 2020 May-Jun:60:33-35. doi: 10.1016/j.jelectrocard.2020.03.010. Epub 2020 Mar 21.

Abstract

About 4.5-20% of patients after heart transplant require pacemaker (PM) implantation. The high infective risk profile and the low probability of pacing dependency make heart-transplanted patients the ideal candidates for a leadless single-chamber PM. We report the first multicenter experience of leadless PM implantation in a series of heart-transplanted patients with a long-term follow-up. Our data confirm the feasibility and acceptable safety of leadless device in this peculiar kind of patients, despite implantation seems to be slightly more challenging with respect to non-transplanted patients. Although more data are required, a leadless single-chamber surveillance PM seems a valuable option for heart-transplanted patients.

Keywords: Heart transplantation; Leadless pacemaker.

Publication types

  • Multicenter Study

MeSH terms

  • Arrhythmias, Cardiac / therapy
  • Electrocardiography
  • Equipment Design
  • Heart Transplantation*
  • Humans
  • Pacemaker, Artificial*
  • Treatment Outcome